Main public logs

Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 08:51, 18 July 2024 Muhammad Waleed talk contribs created page Acute Fibrinous and Organizing Pneumonia (Created page with "__NOTOC__ {{xyz}} '''To view the main page click here.''' {{CMG}}; {{AE}} Person 1, Person 2, Your Name ==Overview== ==Historical Perspective== ==Classification== ==Pathophysiology== ==Causes== ==Type page name here differential diagnosis|Dif...")
• 14:40, 23 May 2024 Muhammad Waleed talk contribs created page Glofitamab-gxbm (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=glofitamab. |aOrAn=a |drugClass=bispecific antibodies |indicationType=treatment |indication=COLUMVI (glofitamab) has been approved by the FDA for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), or large B-cell lymphoma arising from follicular lymphoma aft...")
• 12:43, 23 May 2024 Muhammad Waleed talk contribs created page Rozanolixizumab-noli (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=Rozanolixizumab-noli (Rystiggo) |aOrAn=a |drugClass=Neonatal Fc receptor blocker |indicationType=treatment |indication=Rystiggo is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. |adverseReac...")
• 10:11, 16 May 2024 Muhammad Waleed talk contribs created page Avacincaptad pegol (Created page with "{{DrugProjectFormSinglePage |genericName=Avacincaptad Pegol |drugClass=Avacincaptad pegol is a complement C5 protein inhibitor |indication=IZERVAY is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). |adverseReactions=Common adverse reactions (≥5% of patients) include conjunctival hemorrhage, increased intraocular pressure, and endophthalmitis. |blackBoxWarningTitle=There is no black box warning listed for IZERV...")
• 09:31, 16 May 2024 Muhammad Waleed talk contribs created page File:Talvey (talquetamab-tgvs).png (image for the drug Talvey)
• 09:31, 16 May 2024 Muhammad Waleed talk contribs uploaded File:Talvey (talquetamab-tgvs).png (image for the drug Talvey)
• 20:38, 13 May 2024 Muhammad Waleed talk contribs created page Talquetamab-tgvs (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=Talquetamab-tgvs |aOrAn=a |drugClass=bispecific GPRC5D-directed CD3 T-cell engager |indicationType=treatment |indication=TALVEY is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent...")
• 03:54, 10 August 2023 Muhammad Waleed talk contribs created page Triple M Syndrome (Created page with "__NOTOC__ {{SI}} '''For patient information, click Insert page name here''' {{CMG}} {{SK}} == Overview == ==Historical Perspective== ==Classification== == Pathophysiology== === Genetics === === Associated Conditions=== ===Gross Pathology=== ===Microscopic Pathology=== ==Causes== ===Life Threatening Causes=== Life-threatening causes include conditions which may result in death or permanent disability within 24 ho...")
• 03:29, 10 August 2023 Muhammad Waleed talk contribs created page Template:MWA (Created page with "Muhammad Waleed, M.B.B.S.[mailto:muhammad_waleed@ymail.com]")